Skip to contentN
Neogenomics Inc
N
NEONeogenomics Inc Q2 2018 · 10-Q
Revenue$67.75M$67.75M+8.8% vs Q2 2017 Net Income-$380.00K-$380.00KN/M vs Q2 2017 EPS Diluted$0.07$0.07N/M vs Q2 2017 Gross Profit$30,530,000+11.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
Operating Cash Flowderived$6,640,000+1.7% Free Cash Flowderived$2,363,000+41.4% Margins · derivedGross margin45.1%+1.1 pt vs Q2 2017
Operating margin1.2%−1.8 pt vs Q2 2017
Net margin-0.6%−1.3 pt vs Q2 2017
ended Jun 30, 2018 · filed Aug 6, 2018 · 37 d after period end